Jinxin Fertility Group Limited (HKG:1951)

Market Cap	6.71B -1.8%
Revenue (ttm)	2.91B -8.4%
Net Income	-1.04B
EPS	-0.39
Shares Out	2.71B
PE Ratio	n/a
Forward PE	17.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,118,000
Average Volume	19,622,132
Open	2.430
Previous Close	2.440
Day's Range	2.420 - 2.490
52-Week Range	2.330 - 3.790
Beta	0.93
RSI	51.08
Earnings Date	Mar 30, 2026

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psycholo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1951
• Employees: 3,365
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1951

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in CNY